Metabolic Syndrome in Systemic Lupus Erythematosus: Prevalence, Pathogenesis, and Predictive Markers

Authors

  • Aya Akmal Amin Ahmed, Salah Ahmed Al Baioumy, Eman-Eldessoki El-Shahawy , Hoda Abdin Ebrahim, Dina Mohamed Said Abd El-rahman

Keywords:

Metabolic Syndrome , Systemic Lupus Erythematosus

Abstract

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease associated with increasedcardiovascular risk. Metabolic syndrome (MetS), a cluster of metabolic abnormalities including obesity,dyslipidemia, hypertension, and insulin resistance, is increasingly recognized as a common comorbidity in SLE

References

Urowitz MB, Gladman DD. Evolving concepts in systemic lupus erythematosus. Nat Rev Rheumatol. 2019;15(1):30-38.

Tektonidou MG, Lewandowski LB, Ward MM. Risk of cardiovascular disease in systemic lupus erythematosus: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2016;68(3):292-302.

Downloads

Published

2024-06-20

How to Cite

Aya Akmal Amin Ahmed, Salah Ahmed Al Baioumy, Eman-Eldessoki El-Shahawy , Hoda Abdin Ebrahim, Dina Mohamed Said Abd El-rahman. (2024). Metabolic Syndrome in Systemic Lupus Erythematosus: Prevalence, Pathogenesis, and Predictive Markers . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 2235–2246. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/3237

Issue

Vol. 33 No. 06 (2024): JOCAAA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.